Gammaplex (Immun Glob G(IgG)/Gly/IgA 0-50) Patent Expiration, LOE Window & CMS Spending

Gammaplex (Immun Glob G(IgG)/Gly/IgA 0-50) by Bio Products La: Off-Patent Genericized (AB Competition), 0 AB generics, $342.5M 2024 CMS Part D & Medicaid spend, and 6 CA HCAI SB 17 wholesale price filings.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorBio Products La
FDA Application & PathwayReconciled (UNLINKED)
Exclusivity / Cliff HorizonOff-Patent Genericized (AB Competition)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity DateNot listed / N/A
Orange Book Patents (*PED Extensions)0 patents (0 *PED)
Active AB-Rated Generic Competitors0
2024 CMS Total Public Spend$342.5M
2024 Medicare Part D Spend$294.8M
2024 Medicaid Spend$47.7M
Reported Wholesale Price Change (CA SB 17)6 WAC filings (max 16.4% 2-yr change)